This content is machine translated Bisphosphonates in osteoporosis The benefit outweighs the risk Since their introduction in the 1990s, bisphosphonates have been the drugs of first choice in the treatment of osteoporosis. They inhibit osteoclast-mediated resorption and bone remodeling, increase bone mineral density,…
View Post 3 min This content is machine translated Diabetic kidney disease Canagliflozin approved in fast track for diabetic nephropathy Kidney protection is extremely important for diabetes sufferers. Recently, canagliflozin became the first SGLT-2 inhibitor in Switzerland to receive a marketing authorization extension to reduce the risk of progression to…
